You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME/CE

Framing the Conversation With Parents About the HPV Vaccine

  • Authors: Larry Pickering, MD; Jay E. Berkelhamer, MD; Jamie Loehr, MD; Katherine Brewer, MSN, RN
  • CME/CE Released: 7/18/2014
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 7/18/2015, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This activity is intended for pediatricians, family medicine physicians, and nurses.

The goal of this activity is to educate clinicians on the importance of the human papillomavirus (HPV) vaccine for children approaching adolescence and to provide strategies to educate parents about the importance of the vaccine for their child’s well-being.

Upon completion of this activity, participants will be able to:

  1. Describe the burden of HPV-related disease in the United States
  2. Interpret the Advisory Committee on Immunization Practices recommendations for HPV vaccination
  3. Identify successful strategies for improving HPV vaccination rates


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Larry Pickering, MD

    Adjunct Professor of Pediatrics, Emory University School of Medicine; Senior Advisor to the Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

    Disclosures

    The opinions expressed are those of Dr Pickering and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Pickering’s participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.Disclosure: Larry Pickering, MD, has disclosed no relevant financial relationships.

    Dr Pickering does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Pickering does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Jay E. Berkelhamer, MD

    Adjunct Professor of Pediatrics, Emory University School of Medicine and Morehouse School of Medicine, Atlanta, Georgia

    Disclosures

    The opinions expressed are those of Dr Berkelhamer and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Berkelhamer’s participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.

    Disclosure: Jay E. Berkelhamer, MD, has disclosed no relevant financial relationships.

    Dr Berkelhamer does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Berkelhamer does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Jamie Loehr, MD

    Cayuga Family Medicine, Ithaca, New York

    Disclosures

    Disclosure: Jamie Loehr, MD, has disclosed no relevant financial relationships.

    Dr Loehr does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Loehr does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Katherine Brewer, RN, MSN

    Senior Policy Analyst, Department of Nursing Practice and Policy, American Nurses Association, Silver Spring, Maryland

    Disclosures

    Disclosure: Katherine Brewer, RN, MSN, has disclosed no relevant financial relationships.

    Ms Brewer does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Ms Brewer does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

  • Susan L. Smith, MN, PhD

    Lead Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Susan L. Smith, MN, PhD, has disclosed no relevant financial relationships.

CME Reviewer / Nurse Planner

  • Amy Bernard, MS, BSN, RN-BC

    Lead Nurse Planner, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

    For Nurses

  • Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 0.75 contact hour(s) of continuing nursing education for RNs and APNs; 0.75 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME/CE

Framing the Conversation With Parents About the HPV Vaccine

processing....

Introduction

Numerous prelicensure and postlicensure studies have shown that human papillomavirus (HPV) vaccines are safe and effective. Yet the 2012 HPV vaccination coverage rates demonstrated that only one-half of girls age 13 through 17 years in the United States had started the vaccine series, and only one-third had received the recommended 3 doses. Compared with vaccination coverage by other vaccines recommended routinely for adolescents (ie, meningococcal conjugate and tetanus toxoid, reduced diphtheria toxoid and acellular pertussis [Tdap] vaccines), HPV vaccination coverage is low. In 2012, many states achieved the Healthy People 2020 target for the Tdap vaccine, demonstrating that adolescents’ access to immunizations is not a barrier to achieving high HPV vaccination coverage.[1] These disparities in coverage underscore the fact that opportunities to provide HPV vaccine are being missed.

Educational Impact Challenge

Assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print